EGFR Blockade Enriches for Lung Cancer Stem–like Cells through Notch3-Dependent Signaling
- 30 September 2014
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 74 (19), 5572-5584
- https://doi.org/10.1158/0008-5472.can-13-3724
Abstract
Mutations in the epidermal growth factor receptor (EGFR) are the most common actionable genetic abnormalities yet discovered in lung cancer. However, targeting these mutations with kinase inhibitors is not curative in advanced disease and has yet to demonstrate an impact on potentially curable, early-stage disease, with some data suggesting adverse outcomes. Here, we report that treatment of EGFR-mutated lung cancer cell lines with erlotinib, while showing robust cell death, enriches the ALDH+ stem-like cells through EGFR-dependent activation of Notch3. In addition, we demonstrate that erlotinib treatment increases the clonogenicity of lung cancer cells in a sphere-forming assay, suggesting increased stem-like cell potential. We demonstrate that inhibition of EGFR kinase activity leads to activation of Notch transcriptional targets in a γ secretase inhibitor-sensitive manner and causes Notch activation, leading to an increase in ALDH high+ cells. We also find a kinase-dependent physical association between the Notch3 and EGFR receptors and tyrosine phosphorylation of Notch3. This could explain the worsened survival observed in some studies of erlotinib treatment at early-stage disease, and suggests that specific dual targeting might overcome this adverse effect. Cancer Res; 74(19); 5572–84. ©2014 AACR.Other Versions
This publication has 49 references indexed in Scilit:
- NOTCH1 mutations influence survival in chronic lymphocytic leukemia patientsBMC Cancer, 2013
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 MutationsThe New England Journal of Medicine, 2012
- Concise Review: Emerging Concepts in Clinical Targeting of Cancer Stem CellsThe International Journal of Cell Cloning, 2011
- Notch and EGFR pathway interaction regulates neural stem cell number and self-renewalNature, 2010
- Notch Signaling in Solid TumorsCurrent Topics in Developmental Biology, 2010
- Alterations of the Notch pathway in lung cancerProceedings of the National Academy of Sciences of the United States of America, 2009
- Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bimOncogene, 2009
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaThe New England Journal of Medicine, 2009
- Emerging role of Notch in stem cells and cancerCancer Letters, 2009
- EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancerNature, 2008